Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Operating Expenses | 8,146 | 6,922 | 6,623 | 5,910 | 5,776 |
| Operating Income | -8,146 | -6,922 | -6,623 | -5,910 | -5,776 |
| Other Income | 256 | 155 | 131 | 101 | 93 |
| Pre-tax Income | -7,890 | -6,767 | -6,492 | -5,809 | -5,683 |
| Net Income Continuous | -7,890 | -6,767 | -6,492 | -5,809 | -5,683 |
| Net Income | $-7,890 | $-6,767 | $-6,492 | $-5,809 | $-5,683 |
| EPS Basic Total Ops | -0.29 | -0.29 | -0.30 | -0.28 | -0.29 |
| EPS Basic Continuous Ops | -0.29 | -0.29 | -0.30 | -0.29 | -0.29 |
| EPS Diluted Total Ops | -0.29 | -0.29 | -0.30 | -0.28 | -0.29 |
| EPS Diluted Continuous Ops | -0.29 | -0.29 | -0.30 | -0.29 | -0.29 |
| EBITDA(a) | $-8,001 | $-6,732 | $-6,489 | $-5,795 | $-5,669 |